“…Damage of type I pneumocyte, hyperplasia of type II pneumocytes, and pulmonary interstitial fibrosis has been described secondary to cadmium exposure (Yamamoto, et al, 1983;Oberdöster, 1989;Tátrai, et al, 2001;Kwon, et al, 2003), and in vitro, morphological changes in the membrane of type II pneumocytes due to cadmium-inhibited protein synthesis has also been noted (Tátrai, et al, 2001). In our study, after the cadmium administration, the lungs showed an interstitial pneumonia and hyperplasia of type II pneumocytes, which is related to apoptosis of type I pneumocytes originated by oxidative stress (Kwon, et al, 2003).…”